Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(5alpha,17beta)-17-hydroxyandrostan-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
, 4,9(11)-androstadiene-3,17-dione + acceptor
? + reduced acceptor
11-deoxy-17alpha-hydroxycorticosterone + acceptor
17,21-dihydroxypregna-1,4-diene-3,20-dione + reduced acceptor
-
4-pregnene-17alpha,21-diol-3,20-dione
-
-
?
11-deoxycorticosterone + acceptor
21-hydroxypregna-1,4-diene-3,20-dione + reduced acceptor
-
-
-
?
11alpha-hydroxy-testosterone + acceptor
11alpha,17beta-dihydroxyandrost-1,4-diene-3-one + reduced acceptor
-
-
-
-
?
11alpha-hydroxyprogesterone + acceptor
11alpha-hydroxy-1,4-pregnene-3,20-dione + reduced acceptor
-
4-pregnene-11alpha-ol-3,20-dione
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + 2,6-dichlorphenolindophenol
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced 2,6-dichlorphenolindophenol
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + phenazine methosulfate
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced phenazine methosulfate
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione acetate + reduced acceptor
11beta-cortisol + 2,6-dichlorophenol-indophenol
(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
11beta-hydroxy-4-androstene-3,17-dione + acceptor
11beta-hydroxy-1,4-androstene-3,17-dione + reduced acceptor
11beta-hydroxytestosterone + acceptor
11beta,17beta-dihydroxyandrost-1,4-diene-3-one + reduced acceptor
-
4-androstene-11beta,17beta-diol-3-one
-
-
?
16,17alpha-epoxyprogesterone + acceptor
? + reduced acceptor
-
-
-
?
16alpha,17alpha-epoxyprogesterone + acceptor
? + reduced acceptor
17-methyl-testosterone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
17alpha,21-dihydroxyprogesterone 21-acetate + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
Reichstein substance S 21-acetate (RSA), best substrate
-
-
?
17alpha,21-dihydroxyprogesterone 21-acetate + acceptor
? + reduced acceptor
RSA
-
-
?
17alpha-hydroxy-progesterone + acceptor
1,4-pregnene-17alpha-ol-3,20-dione + reduced acceptor
-
4-pregnene-17alpha-ol-3,20-dione
-
-
?
17alpha-hydroxypregn-4-ene-3,20-dione + acceptor
1,4-pregnene-17alpha-ol-3,20-dione + reduced acceptor
-
-
-
?
17alpha-hydroxypregn-4-ene-3,20-dione + acceptor
? + reduced acceptor
17alpha-hydroxyprogesterone + 2,6-dichlorophenol-indophenol
17alpha-hydroxy-pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
17alpha-hydroxyprogesterone + acceptor
17alpha-hydroxy-pregna-1,4-diene-3,20-dione + reduced acceptor
-
-
-
?
17alpha-methyltestosterone + acceptor
17alpha-methylandrost-1,4-diene-3-one + reduced acceptor
-
-
-
-
?
19-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
19-hydroxy-androst-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
19-nor-4-androstene-3,17-dione + acceptor
19-nor-1,4-androstene-3,17-dione + reduced acceptor
-
4-estren-3,17-dione
-
-
?
19-nortestosterone + acceptor
17beta-hydroxy-1,4-estrene-3-one + reduced acceptor
-
4-estren-17beta-ol-3-one
-
-
?
21-acetoxy-pregna-4,9(11),16-triene-3,20-dinone + acceptor
? + reduced acceptor
21-chloro-17-hydroxy-pregna-4,9(11)-diene-3,20-dione + acceptor
? + reduced acceptor
22-hydroxy-23, 24-bisnorchola-4-en-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
23,24-bis-nor-5alpha-cholestan-3-one acid + 2,6-dichlorophenol-indophenol
?
25-hydroxycholest-4-en-3-one + acceptor
? + reduced acceptor
-
-
-
?
3-oxo-5beta-cholan-24-oic acid + acceptor
? + reduced acceptor
-
-
-
-
?
3-oxosteroid + acceptor
3-oxo-DELTA1-steroid + reduced acceptor
-
key catalyst in microbial steroid metabolism
-
-
?
4-androsten-3-one-5-ene-17-carboxylic acid + acceptor
? + reduced acceptor
4-androstene-17beta-ol-3-one + 2,6-dichlorophenol-indophenol
1,4-androstadiene-17beta-ol-3-one + reduced 2,6-dichlorophenol-indophenol
4-androstene-3,11,17-trione + acceptor
1,4-androstene-3,11,17-trione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
4-androstene-3,17-dione + phenazine methosulfate
1,4-androstadiene-3,17-dione + reduced phenazine methosulfate
-
-
-
-
r
4-androstene-3,17-dione + phenazine methosulfate
1,4-androstene-3,17-dione + reduced phenazine methosulfate
-
-
-
-
?
4-cholesten-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
4-cholesten-3-one + 2,6-dichlorophenol-indophenol
? + reduced acceptor
4-cholesten-3-one + acceptor
? + reduced acceptor
-
-
-
?
4-pregnen-3-one-20beta-carboxylic acid + 2,6-dichlorophenol-indophenol
pregna-1,4-dien-3-one-20beta-carboxylic acid + reduced 2,6-dichlorophenol-indophenol
4-pregnene-3,20-dione + acceptor
1,4-pregnene-3,20 dione + reduced acceptor
5alpha-androst-1-en-3-one + acceptor
5alpha-androstan-3-one + reduced acceptor
-
-
-
-
?
5alpha-androstan-3-one-17beta-ol + 2,6-dichlorophenol-indophenol
(5alpha,17beta)-17-hydroxyandrost-1-en-3-one + reduced 2,6-dichlorophenol-indophenol
5alpha-androstane-17beta-ol-3-one + 2,6-dichlorophenol-indophenol
5alpha-androst-1-ene-17beta-ol-3-one + reduced 2,6-dichlorophenol-indophenol
5alpha-androstane-3,17-dione + 2,6-dichlorophenol-indophenol
5beta-androst-1-en-3,17-dione + reduced 2,6-dichlorophenol-indophenol
5alpha-pregnane-3,20-dione + 2,6-dichlorophenol-indophenol
5alpha-pregn-1-en-3,20-dione + reduced 2,6-dichlorophenol-indophenol
5beta-androstan-3,17-dione + acceptor
5beta-androst-1-en-3,17-dione + reduced acceptor
-
-
-
-
?
6-dehydrotestosterone acetate + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
9,22-dihydroxy-23,24-bisnorchol-4-ene-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced 2,6-dichlorophenol-indophenol
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-androst-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxyandrost-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
? + reduced acceptor
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + FAD
9alpha-hydroxy-1,4-androstadiene-3,17-dione + FADH2
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
androst-4,9(11)-diene-3,17-dione + acceptor
? + reduced acceptor
androst-4-ene-3,17-dione + acceptor
androsta-1,4-diene-3,17-dione + reduced acceptor
androsta-4,9(11)-diene-3,17-dione + acceptor
? + reduced acceptor
NSC 44826
-
-
?
androstanolone + acceptor
? + reduced acceptor
androsterone + acceptor
3-alpha-hydroxy-1-androstene-17-one + reduced acceptor
-
4-androstene-3,11,17-trione
-
-
?
canrenone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
best substrate
-
-
?
canrenone + acceptor
? + reduced acceptor
-
-
-
?
cortexolone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
corticosterone + 2,6-dichlorophenol-indophenol
1,4-pregnene-17alpha,21-diol-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
corticosterone + acceptor
1,4-pregnene-17alpha,21-diol-3,20-dione + reduced acceptor
-
4-pregnene-11beta,21-diol-3,20-dione
-
-
?
cortisol + acceptor
prednisolone + reduced acceptor
-
optimal concentration is 0.1 mg/ml, increase of concentration to 1 mg/ml reduces prednisolone yield
-
-
?
cortisone + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
cortisone + acceptor
? + reduced acceptor
cortisone + acceptor
prednisone + reduced acceptor
-
-
-
?
cortisone acetate + 2,6-dichlorophenol-indophenol
prednisolone acetate + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
deoxycorticosterone + 2,6-dichlorophenol-indophenol
1,4-pregnadiene-21-ol-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
deoxycorticosterone + 2,6-dichlorophenol-indophenol
1,4-pregnene-21-ol-3,20-dione + reduced 2,6-dichlorophenol-indophenol
deoxycorticosterone + acceptor
1,4-pregnene-21-ol-3,20-dione + reduced acceptor
-
4-pregnene-21-ol-3,20-dione
-
-
?
dihydrotestosterone + acceptor
? + reduced acceptor
-
-
-
?
diosgenone + acceptor
? + reduced acceptor
hydrocorticosterone + acceptor
1,4-pregnene-11beta,17alpha,21-triol-3,20-dione + reduced acceptor
-
4-pregnene-11beta,17alpha,21triol-3,20-dione
-
-
?
hydrocortisone 21-hemisuccinate + acceptor
? + reduced acceptor
-
-
-
?
prednisolone + acceptor
? + reduced acceptor
-
-
-
?
pregn-4-ene-3,20-dione + acceptor
pregn-1,4-diene-3,20-dione + reduced acceptor
pregna-4,9(11),16-triene-3,20-dione + acceptor
? + reduced acceptor
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
progesterone + acceptor
? + reduced acceptor
-
-
-
-
?
progesterone + acceptor
pregna-1,4-diene-3,20-dione + reduced acceptor
spironolactone + acceptor
? + reduced acceptor
-
-
-
?
testololactone + acceptor
D-homo-17alpha-oxoandrosta-1,4-diene-3,17-one + reduced acceptor
-
D-homo-17a-oxoandrost-4-ene-3,17-dione
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
testosterone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
testosterone + acceptor
17beta-hydroxyandrost-1,4-diene-3-one + reduced acceptor
testosterone propionate + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one propionate + reduced 2,6-dichlorophenol-indophenol
additional information
?
-
(5alpha,17beta)-17-hydroxyandrostan-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
(5alpha,17beta)-17-hydroxyandrostan-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
, 4,9(11)-androstadiene-3,17-dione + acceptor
? + reduced acceptor
-
-
-
-
?
, 4,9(11)-androstadiene-3,17-dione + acceptor
? + reduced acceptor
-
-
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + 2,6-dichlorphenolindophenol
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced 2,6-dichlorphenolindophenol
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + 2,6-dichlorphenolindophenol
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced 2,6-dichlorphenolindophenol
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + phenazine methosulfate
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced phenazine methosulfate
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione + phenazine methosulfate
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced phenazine methosulfate
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione acetate + reduced acceptor
hydrocortisone acetate
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione acetate + reduced acceptor
hydrocortisone acetate
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione acetate + reduced acceptor
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione acetate + reduced acceptor
hydrocortisone acetate
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione acetate + reduced acceptor
hydrocortisone
-
-
?
11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione acetate + reduced acceptor
hydrocortisone acetate
-
-
?
11beta-cortisol + 2,6-dichlorophenol-indophenol
(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
11beta-cortisol + 2,6-dichlorophenol-indophenol
(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
11beta-hydroxy-4-androstene-3,17-dione + acceptor
11beta-hydroxy-1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
?
11beta-hydroxy-4-androstene-3,17-dione + acceptor
11beta-hydroxy-1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
?
16alpha,17alpha-epoxyprogesterone + acceptor
? + reduced acceptor
-
-
-
-
?
16alpha,17alpha-epoxyprogesterone + acceptor
? + reduced acceptor
-
-
-
-
?
17alpha-hydroxypregn-4-ene-3,20-dione + acceptor
? + reduced acceptor
-
-
-
?
17alpha-hydroxypregn-4-ene-3,20-dione + acceptor
? + reduced acceptor
-
-
-
?
19-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
19-hydroxy-androst-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
19-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
19-hydroxy-androst-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
21-acetoxy-pregna-4,9(11),16-triene-3,20-dinone + acceptor
? + reduced acceptor
-
-
-
?
21-acetoxy-pregna-4,9(11),16-triene-3,20-dinone + acceptor
? + reduced acceptor
-
-
-
?
21-chloro-17-hydroxy-pregna-4,9(11)-diene-3,20-dione + acceptor
? + reduced acceptor
-
-
-
?
21-chloro-17-hydroxy-pregna-4,9(11)-diene-3,20-dione + acceptor
? + reduced acceptor
-
-
-
?
22-hydroxy-23, 24-bisnorchola-4-en-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
22-hydroxy-23, 24-bisnorchola-4-en-3-one + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
23,24-bis-nor-5alpha-cholestan-3-one acid + 2,6-dichlorophenol-indophenol
?
-
-
-
?
23,24-bis-nor-5alpha-cholestan-3-one acid + 2,6-dichlorophenol-indophenol
?
-
-
-
?
4-androsten-3-one-5-ene-17-carboxylic acid + acceptor
? + reduced acceptor
-
-
-
?
4-androsten-3-one-5-ene-17-carboxylic acid + acceptor
? + reduced acceptor
-
-
-
?
4-androstene-17beta-ol-3-one + 2,6-dichlorophenol-indophenol
1,4-androstadiene-17beta-ol-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-17beta-ol-3-one + 2,6-dichlorophenol-indophenol
1,4-androstadiene-17beta-ol-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstadiene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
1,4-androstene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
involved in steroid catabolism
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
acceptor: phenazine methosulfate/2,6-dichlorophenolindophenol system. The enzyme does not show any activity in presence of nitro blue tetrazolium
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
KSTD1, which is reported to be inactive with this substrates can catalyze the reaction if the solubility problem is addressed, e.g. by 2-hydroxpropyl-beta-cyclodextrin
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
involved in steroid catabolism
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
acceptor: phenazine methosulfate/2,6-dichlorophenolindophenol system. The enzyme does not show any activity in presence of nitro blue tetrazolium
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstadiene-3,17-dione + reduced acceptor
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
ir
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
?
4-androstene-3,17-dione + acceptor
1,4-androstene-3,17-dione + reduced acceptor
-
-
-
-
r
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
-
r
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
-
r
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
with artificial electron acceptors phenazine methosulfate and dichlorophenolindophenol
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
with artificial electron acceptors phenazine methosulfate and dichlorophenolindophenol
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
residues Y122, Y125, S138, E140, and Y541 from the FAD-binding domain and Y365 from the catalytic domain play a key role in this reaction
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
with artificial electron acceptors phenazine methosulfate and dichlorophenolindophenol
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
residues Y122, Y125, S138, E140, and Y541 from the FAD-binding domain and Y365 from the catalytic domain play a key role in this reaction
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
with artificial electron acceptors phenazine methosulfate and dichlorophenolindophenol
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
residues Y122, Y125, S138, E140, and Y541 from the FAD-binding domain and Y365 from the catalytic domain play a key role in this reaction
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
4-androstene-3,17-dione + FAD
1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
4-cholesten-3-one + 2,6-dichlorophenol-indophenol
? + reduced acceptor
-
-
-
?
4-cholesten-3-one + 2,6-dichlorophenol-indophenol
? + reduced acceptor
-
-
-
?
4-pregnen-3-one-20beta-carboxylic acid + 2,6-dichlorophenol-indophenol
pregna-1,4-dien-3-one-20beta-carboxylic acid + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-pregnen-3-one-20beta-carboxylic acid + 2,6-dichlorophenol-indophenol
pregna-1,4-dien-3-one-20beta-carboxylic acid + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
4-pregnene-3,20-dione + acceptor
1,4-pregnene-3,20 dione + reduced acceptor
-
-
-
-
?
4-pregnene-3,20-dione + acceptor
1,4-pregnene-3,20 dione + reduced acceptor
-
-
-
-
?
4-pregnene-3,20-dione + acceptor
1,4-pregnene-3,20 dione + reduced acceptor
-
-
-
?
4-pregnene-3,20-dione + acceptor
1,4-pregnene-3,20 dione + reduced acceptor
-
-
-
?
5alpha-androstan-3-one-17beta-ol + 2,6-dichlorophenol-indophenol
(5alpha,17beta)-17-hydroxyandrost-1-en-3-one + reduced 2,6-dichlorophenol-indophenol
-
KSTD3 shows highest activity on 5alpha-testosterone which is also known as 17beta-hydroxy-5alpha-androstane-3-one
-
-
?
5alpha-androstan-3-one-17beta-ol + 2,6-dichlorophenol-indophenol
(5alpha,17beta)-17-hydroxyandrost-1-en-3-one + reduced 2,6-dichlorophenol-indophenol
-
KSTD3 shows highest activity on 5alpha-testosterone which is also known as 17beta-hydroxy-5alpha-androstane-3-one
-
-
?
5alpha-androstan-3-one-17beta-ol + 2,6-dichlorophenol-indophenol
(5alpha,17beta)-17-hydroxyandrost-1-en-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
5alpha-androstan-3-one-17beta-ol + 2,6-dichlorophenol-indophenol
(5alpha,17beta)-17-hydroxyandrost-1-en-3-one + reduced 2,6-dichlorophenol-indophenol
KSTD3 shows highest activity on 5alpha-androstan-3-one-17beta-ol which is also known as 17beta-hydroxy-5alpha-androstane-3-one
-
-
?
5alpha-androstan-3-one-17beta-ol + 2,6-dichlorophenol-indophenol
(5alpha,17beta)-17-hydroxyandrost-1-en-3-one + reduced 2,6-dichlorophenol-indophenol
KSTD3 shows highest activity on 5alpha-androstan-3-one-17beta-ol which is also known as 17beta-hydroxy-5alpha-androstane-3-one
-
-
?
5alpha-androstan-3-one-17beta-ol + 2,6-dichlorophenol-indophenol
(5alpha,17beta)-17-hydroxyandrost-1-en-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
5alpha-androstane-17beta-ol-3-one + 2,6-dichlorophenol-indophenol
5alpha-androst-1-ene-17beta-ol-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
5alpha-androstane-17beta-ol-3-one + 2,6-dichlorophenol-indophenol
5alpha-androst-1-ene-17beta-ol-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
5alpha-androstane-3,17-dione + 2,6-dichlorophenol-indophenol
5beta-androst-1-en-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
KSTD3 shows highest activity with 5alpha-androstane-3,17-dione
-
-
?
5alpha-androstane-3,17-dione + 2,6-dichlorophenol-indophenol
5beta-androst-1-en-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
KSTD3 shows highest activity with 5alpha-androstane-3,17-dione
-
-
?
5alpha-androstane-3,17-dione + 2,6-dichlorophenol-indophenol
5beta-androst-1-en-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
5alpha-androstane-3,17-dione + 2,6-dichlorophenol-indophenol
5beta-androst-1-en-3,17-dione + reduced 2,6-dichlorophenol-indophenol
KSTD3 shows highest activity with 5alpha-androstane-3,17-dione
-
-
?
5alpha-androstane-3,17-dione + 2,6-dichlorophenol-indophenol
5beta-androst-1-en-3,17-dione + reduced 2,6-dichlorophenol-indophenol
KSTD3 shows highest activity with 5alpha-androstane-3,17-dione
-
-
?
5alpha-pregnane-3,20-dione + 2,6-dichlorophenol-indophenol
5alpha-pregn-1-en-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
5alpha-pregnane-3,20-dione + 2,6-dichlorophenol-indophenol
5alpha-pregn-1-en-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
6-dehydrotestosterone acetate + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
6-dehydrotestosterone acetate + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced 2,6-dichlorophenol-indophenol
preferred substrate of isozyme KSTD2
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-androst-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-androst-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxy-androst-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxyandrost-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxyandrost-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxyandrost-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + 2,6-dichlorophenol-indophenol
9alpha-hydroxyandrost-1,4-diene-3,17-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
involved in steroid catabolism
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
acceptor: phenazine methosulfate/2,6-dichlorophenolindophenol system. The enzyme does not show any activity in presence of nitro blue tetrazolium
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
involved in steroid catabolism
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
acceptor: phenazine methosulfate/2,6-dichlorophenolindophenol system. The enzyme does not show any activity in presence of nitro blue tetrazolium
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + acceptor
9alpha-hydroxy-1,4-androstadiene 3,17-dione + reduced acceptor
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + FAD
9alpha-hydroxy-1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
9alpha-hydroxy-4-androstene-3,17-dione + FAD
9alpha-hydroxy-1,4-androstadiene-3,17-dione + FADH2
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
a 3-oxosteroid + acceptor
a 3-oxo-delta1-steroid + reduced acceptor
-
-
-
?
androst-4,9(11)-diene-3,17-dione + acceptor
? + reduced acceptor
-
-
-
?
androst-4,9(11)-diene-3,17-dione + acceptor
? + reduced acceptor
-
-
-
?
androst-4-ene-3,17-dione + acceptor
androsta-1,4-diene-3,17-dione + reduced acceptor
-
-
-
?
androst-4-ene-3,17-dione + acceptor
androsta-1,4-diene-3,17-dione + reduced acceptor
-
-
-
?
androstanolone + acceptor
? + reduced acceptor
-
-
-
?
androstanolone + acceptor
? + reduced acceptor
-
-
-
?
cholesterol + acceptor
?
-
KsdD2 exhibits low but detectable activity in the cholesterol degradation process
-
-
?
cholesterol + acceptor
?
-
KsdD2 exhibits low but detectable activity in the cholesterol degradation process
-
-
?
cortexolone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
cortexolone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
cortisone + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
-
4-pregnene-17alpha,21-diol-3,11,20-trione
-
-
?
cortisone + acceptor
1,4-pregnene-17alpha,21-diol-3,11,20-trione + reduced acceptor
-
-
-
-
?
cortisone + acceptor
? + reduced acceptor
-
-
-
?
cortisone + acceptor
? + reduced acceptor
-
-
-
?
deoxycorticosterone + 2,6-dichlorophenol-indophenol
1,4-pregnene-21-ol-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
deoxycorticosterone + 2,6-dichlorophenol-indophenol
1,4-pregnene-21-ol-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
diosgenone + acceptor
? + reduced acceptor
-
-
-
?
diosgenone + acceptor
? + reduced acceptor
-
-
-
?
pregn-4-ene-3,20-dione + acceptor
pregn-1,4-diene-3,20-dione + reduced acceptor
preferred substrate by synthetic recombinant enzyme DELTA1-KstDR
-
-
?
pregn-4-ene-3,20-dione + acceptor
pregn-1,4-diene-3,20-dione + reduced acceptor
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
progesterone + 2,6-dichlorophenol-indophenol
pregna-1,4-diene-3,20-dione + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
progesterone + acceptor
pregna-1,4-diene-3,20-dione + reduced acceptor
-
-
-
?
progesterone + acceptor
pregna-1,4-diene-3,20-dione + reduced acceptor
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + 2,6-dichlorophenol-indophenol
? + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone + acceptor
17beta-hydroxyandrost-1,4-diene-3-one + reduced acceptor
-
-
-
-
?
testosterone + acceptor
17beta-hydroxyandrost-1,4-diene-3-one + reduced acceptor
-
-
-
-
?
testosterone + acceptor
17beta-hydroxyandrost-1,4-diene-3-one + reduced acceptor
-
-
-
?
testosterone propionate + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one propionate + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
testosterone propionate + 2,6-dichlorophenol-indophenol
17beta-hydroxyandrost-1,4-diene-3-one propionate + reduced 2,6-dichlorophenol-indophenol
-
-
-
?
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
-
acceptor: O2
-
-
?
additional information
?
-
-
3-oxo-5beta-steroid DELTA1-dehydrogenase is active only on 5beta-steroids
-
-
?
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
enzyme works in an early step of steroid degradation
-
-
?
additional information
?
-
enzyme works in an early step of steroid degradation
-
-
?
additional information
?
-
-
KstD3 is active on a broad spectrum of substrates, comprising AD, progesterone, 4,9(11)-androstadiene-3,17-dione and 16alpha,17alpha-epoxyprogesterone. As usually the case with KstDs, the recombinant dehydrogenase is active neither with 3beta-/3alpha-hydroxysteroid nor with 3-ketosteroid containing a bulky C17-side chain, like 4-cholestene-3-one
-
-
-
additional information
?
-
-
KstD3 is active on a broad spectrum of substrates, comprising AD, progesterone, 4,9(11)-androstadiene-3,17-dione and 16alpha,17alpha-epoxyprogesterone. As usually the case with KstDs, the recombinant dehydrogenase is active neither with 3beta-/3alpha-hydroxysteroid nor with 3-ketosteroid containing a bulky C17-side chain, like 4-cholestene-3-one
-
-
-
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
-
acceptor: O2
-
-
?
additional information
?
-
-
acceptor: O2
-
-
?
additional information
?
-
-
not: 3beta-hydroxysteroid, no electron acceptor: NADP+, K3Fe(CN)6, cytochrome c, 3-ketosteroids with a 11alpha- or 11beta-hydroxyl group are oxidized at slow rate, catalyzes aromatization of the A-ring of 19-nortestosterone and 19-norandrostenedione to produce estradiol and estrone, 19-hydroxytestosterone, 19-hydroxyandrosterone, 19-hydroxyandrostenedione and 19-oxotestosterone are converted to the respective phenolic steroids with cleavage of the C10 side-chain
-
-
?
additional information
?
-
-
the purified KstD catalyzes hydrogen transfer from 3-keto-4-ene-steroid (donor) into 3-keto-1,4-diene-steroid (acceptor), e.g. progesterone to 1,4-androstadiene-3,17-dione (ADD). The transhydrogenation reaction reaches equilibrium, and obeys to a typical ping-pong mechanism in which the donor is the first substrate, while the acceptor is the second. The transhydrogenation turnover number is of the same magnitude as that of the C1,2-dehydrogenation
-
-
-
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
-
acceptor: menadione
-
-
?
additional information
?
-
-
acceptor: vitamin K2 (35), only 1-4% product formation as compared to 85-98% formation of 1,4-androstadiene-3,17-dione when phenazine methosulfate or menadione are used
-
-
?
additional information
?
-
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bisnor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 5alpha-pregnane-3,20-dione, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol, 17-one are no substrates
-
-
?
additional information
?
-
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bisnor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 5alpha-pregnane-3,20-dione, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol, 17-one are no substrates
-
-
?
additional information
?
-
among the three KstD isozymes, KstD2 shows the highest enzymatic activity when expressed heterogeneously, and KstD1 performs poorly, especially in Escherichia coli. For isozyme KstD3, the KstD enzyme activities are hardly detected in either host, Escherichia coli or Bacillus subtilis
-
-
-
additional information
?
-
among the three KstD isozymes, KstD2 shows the highest enzymatic activity when expressed heterogeneously, and KstD1 performs poorly, especially in Escherichia coli. For isozyme KstD3, the KstD enzyme activities are hardly detected in either host, Escherichia coli or Bacillus subtilis
-
-
-
additional information
?
-
among the three KstD isozymes, KstD2 shows the highest enzymatic activity when expressed heterogeneously, and KstD1 performs poorly, especially in Escherichia coli. For isozyme KstD3, the KstD enzyme activities are hardly detected in either host, Escherichia coli or Bacillus subtilis
-
-
-
additional information
?
-
-
among the three KstD isozymes, KstD2 shows the highest enzymatic activity when expressed heterogeneously, and KstD1 performs poorly, especially in Escherichia coli. For isozyme KstD3, the KstD enzyme activities are hardly detected in either host, Escherichia coli or Bacillus subtilis
-
-
-
additional information
?
-
enzyme KstD2 displays a high activity on a range of substrates, including 17alpha-hydroxypregn-4-ene-3,20-dione (17alpha-OH-P), androsta-4,9(11)-diene-3,17-dione (NSC 44826), and 4-androstene-3,17-dione (AD), substrate activity and kinetics, overview
-
-
-
additional information
?
-
-
enzyme KstD2 displays a high activity on a range of substrates, including 17alpha-hydroxypregn-4-ene-3,20-dione (17alpha-OH-P), androsta-4,9(11)-diene-3,17-dione (NSC 44826), and 4-androstene-3,17-dione (AD), substrate activity and kinetics, overview
-
-
-
additional information
?
-
among the three KstD isozymes, KstD2 shows the highest enzymatic activity when expressed heterogeneously, and KstD1 performs poorly, especially in Escherichia coli. For isozyme KstD3, the KstD enzyme activities are hardly detected in either host, Escherichia coli or Bacillus subtilis
-
-
-
additional information
?
-
among the three KstD isozymes, KstD2 shows the highest enzymatic activity when expressed heterogeneously, and KstD1 performs poorly, especially in Escherichia coli. For isozyme KstD3, the KstD enzyme activities are hardly detected in either host, Escherichia coli or Bacillus subtilis
-
-
-
additional information
?
-
among the three KstD isozymes, KstD2 shows the highest enzymatic activity when expressed heterogeneously, and KstD1 performs poorly, especially in Escherichia coli. For isozyme KstD3, the KstD enzyme activities are hardly detected in either host, Escherichia coli or Bacillus subtilis
-
-
-
additional information
?
-
enzyme KstD2 displays a high activity on a range of substrates, including 17alpha-hydroxypregn-4-ene-3,20-dione (17alpha-OH-P), androsta-4,9(11)-diene-3,17-dione (NSC 44826), and 4-androstene-3,17-dione (AD), substrate activity and kinetics, overview
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
the purified KstD from Mycobacterium smegmatis mc2155 displays high catalytic efficiency toward hydrocortisone, progesterone, and 9alpha-hydroxy-4-androstene-3,17-dione (9-OH-AD), and has highest affinity toward 9-OH-AD. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization. No or poor activity with 11beta,17-dihydroxy-6alpha-methyl-pregn-4-ene-3,20-dione and anecortave
-
-
-
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
-
acceptor: menadione
-
-
?
additional information
?
-
-
substrate must have a 3-oxo-group, a DELTA4-double bond and axial hydrogens at 1alpha and 2beta positions
-
-
?
additional information
?
-
-
assay and detection with phenazine methosulfate (PMS) and 2,6-dichlorophenloindophenol (DCPIP). Catalytic activity and substrate profile of isozyme KsdD3, each KsdD isozyme exhibits distinct substrate profile, overview. KsdD3 is most active and versatile isozyme from Arthrobacter simplex. No activity of KsdD3 with 9alpha-hydroxy-4-androstene-3,17-dione, 17alpha-hydroxyprogesterone, 17alpha,21-dihydroxyprogesterone 21-acetate (RSA), dehydroepiandrosterone, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate, cortisone acetate, 5alpha-androstane-17beta-ol-3-one, and 5alpha-pregnane-3,20-dione
-
-
-
additional information
?
-
-
assay with phenazine methosulfate (PMS) and 2,6-dichlorophenloindophenol (DCPIP). Catalytic activity and substrate profile of isozyme KsdD5, each KsdD isozyme exhibits distinct substrate profile, overview. No activity of KsdD5 with 9alpha-hydroxy-4-androstene-3,17-dione, canrenone, 4-cholest-3-one, dehydroepiandrosterone, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate, 5alpha-androstane-17beta-ol-3-one, and 5alpha-pregnane-3,20-dione
-
-
-
additional information
?
-
-
assay and detection with phenazine methosulfate (PMS) and 2,6-dichlorophenloindophenol (DCPIP). Catalytic activity and substrate profile of isozyme KsdD3, each KsdD isozyme exhibits distinct substrate profile, overview. KsdD3 is most active and versatile isozyme from Arthrobacter simplex. No activity of KsdD3 with 9alpha-hydroxy-4-androstene-3,17-dione, 17alpha-hydroxyprogesterone, 17alpha,21-dihydroxyprogesterone 21-acetate (RSA), dehydroepiandrosterone, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate, cortisone acetate, 5alpha-androstane-17beta-ol-3-one, and 5alpha-pregnane-3,20-dione
-
-
-
additional information
?
-
-
assay with phenazine methosulfate (PMS) and 2,6-dichlorophenloindophenol (DCPIP). Catalytic activity and substrate profile of isozyme KsdD5, each KsdD isozyme exhibits distinct substrate profile, overview. No activity of KsdD5 with 9alpha-hydroxy-4-androstene-3,17-dione, canrenone, 4-cholest-3-one, dehydroepiandrosterone, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione, 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione acetate, 5alpha-androstane-17beta-ol-3-one, and 5alpha-pregnane-3,20-dione
-
-
-
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
-
acceptor: menadione
-
-
?
additional information
?
-
-
acceptor: vitamin K2 (35), only 1-4% product formation as compared to 85-98% formation of 1,4-androstadiene-3,17-dione when phenazine methosulfate or menadione are used
-
-
?
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
-
acceptor: menadione
-
-
?
additional information
?
-
-
acceptor: vitamin K2 (35), only 1-4% product formation as compared to 85-98% formation of 1,4-androstadiene-3,17-dione when phenazine methosulfate or menadione are used
-
-
?
additional information
?
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
in catalytic mechanism Tyr487 and Gly491 work in tandem to promote keto-enol tautomerization and increase the acidity of the C2 hydrogen atoms of the substrate. With assistance of Tyr119, the general base Tyr318 abstracts the axialbeta-hydrogen from C2 as a proton, whereas the FAD accepts the axial alpha-hydrogen from the C1 atom of the substrate as a hydride ion
-
-
?
additional information
?
-
3-ketosteroid DELTA1-dehydrogenase (DELTA1-KstD) catalyzes the C-1 and C-2 desaturation of ring A. A direct-coupled flurometric assay is developed based on resazurin, which is a weakly fluorescent redox dye that is irreversibly reduced when it accepts protons released from a donor molecule. Reduction of resazurin results in the formation of the highly fluorescent product, resorufin. In this assay, DELTA1-KstDR removes and donates two protons and two electrons from C-1 and C-2 of ring-A directly to resazurin, resulting in the formation of resorufin and water. This reduction can be measured by monitoring the increase in fluorescence intensity with time, allowing the assessment of the initial rates of DELTA1-KstDR substrate conversion. Substrate specificity analysis of the recombinant enzyme DELTA1-KstDR, overview. Poor or no activity with mifepristone, cholesterol, pregnenolone, dehydroepiandrosterone, corticosterone, 7beta-hydroxycholestenone, prednisolone, cholestenone, and aldosterone
-
-
-
additional information
?
-
enzyme substrate specificity, structure-function analysis. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. Enzyme KSTD1 prefers smaller 3-oxosteroids
-
-
-
additional information
?
-
-
enzyme substrate specificity, structure-function analysis. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. Enzyme KSTD1 prefers smaller 3-oxosteroids
-
-
-
additional information
?
-
KstD from Rhodococcus erythropolis WY 1406 exhibits high catalytic efficiency toward androst-4,9(11)-diene-3,17-dione, 21-acetoxy-pregna-4,9(11),16-triene-3,20-dione, and cortexolone, where in all three cases the Km values are 2.5-4fold lower than that toward hydrocortisone. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization
-
-
-
additional information
?
-
-
KstD from Rhodococcus erythropolis WY 1406 exhibits high catalytic efficiency toward androst-4,9(11)-diene-3,17-dione, 21-acetoxy-pregna-4,9(11),16-triene-3,20-dione, and cortexolone, where in all three cases the Km values are 2.5-4fold lower than that toward hydrocortisone. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization
-
-
-
additional information
?
-
KstD from Rhodococcus erythropolis WY 1406 exhibits high catalytic efficiency toward androst-4,9(11)-diene-3,17-dione, 21-acetoxy-pregna-4,9(11),16-triene-3,20-dione, and cortexolone, where in all three cases the Km values are 2.5-4fold lower than that toward hydrocortisone. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization
-
-
-
additional information
?
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
-
4-androstene-3,17-dione, 9alpha-hydroxy-4-androstene-3,17-dione, 11beta-cortisol, 23,24-bis-nor-5alpha-cholestan-3-one acid, 5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
-
5beta-androstane-3,17-dione, [1-(5alpha)-androstene-3,17-dione], 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
in catalytic mechanism Tyr487 and Gly491 work in tandem to promote keto-enol tautomerization and increase the acidity of the C2 hydrogen atoms of the substrate. With assistance of Tyr119, the general base Tyr318 abstracts the axialbeta-hydrogen from C2 as a proton, whereas the FAD accepts the axial alpha-hydrogen from the C1 atom of the substrate as a hydride ion
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
-
5beta-androstane-3,17-dione, 1-(5alpha)-androstene-3,17-dione, 11alpha-hydroxy-4-norandrostene-3,17-dione, 1,4-androstadiene-3,17-dione, dehydroisoandrosterone, 4-cholesten-3-one, 5alpha-cholestan-3-one, and 5alpha-androstan-3beta-ol,17-one are no substrates
-
-
?
additional information
?
-
KstD from Rhodococcus erythropolis WY 1406 exhibits high catalytic efficiency toward androst-4,9(11)-diene-3,17-dione, 21-acetoxy-pregna-4,9(11),16-triene-3,20-dione, and cortexolone, where in all three cases the Km values are 2.5-4fold lower than that toward hydrocortisone. 4-Androstene-3,17-dione is a good substrate. Substrate specificity, overview. Assay method evaluation and optimization
-
-
-
additional information
?
-
-
acceptor: phenazine methosulfate
-
-
?
additional information
?
-
-
acceptor: quinones
-
-
?
additional information
?
-
-
no electron acceptor: NAD+, NADP+
-
-
?
additional information
?
-
3-ketosteroid DELTA1-dehydrogenase (DELTA1-KstD) catalyzes the C-1 and C-2 desaturation of ring A
-
-
-
additional information
?
-
enzyme substrate specificity, structure-function analysis. Conversion of 4-androstene-3,17-dione and cholest-4-en-3-one by isozyme AcmB2 proceeds at a similar rate. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. AcmB2 shows ability to catalyze DELTA1-dehydrogenation of steroids with the aliphatic side chain on the C17 position
-
-
-
additional information
?
-
enzyme substrate specificity, structure-function analysis. Conversion of 4-androstene-3,17-dione and cholest-4-en-3-one by isozyme AcmB2 proceeds at a similar rate. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. AcmB2 shows ability to catalyze DELTA1-dehydrogenation of steroids with the aliphatic side chain on the C17 position
-
-
-
additional information
?
-
-
enzyme substrate specificity, structure-function analysis. Conversion of 4-androstene-3,17-dione and cholest-4-en-3-one by isozyme AcmB2 proceeds at a similar rate. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. AcmB2 shows ability to catalyze DELTA1-dehydrogenation of steroids with the aliphatic side chain on the C17 position
-
-
-
additional information
?
-
enzyme substrate specificity, structure-function analysis. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. AcmB shows ability to catalyze DELTA1-dehydrogenation of steroids with the aliphatic side chain on the C17 position. AcmB indeed exhibits a significantly higher affinity to cholest-4-en-3-one than to 4-androstene-3,17-dione
-
-
-
additional information
?
-
enzyme substrate specificity, structure-function analysis. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. AcmB shows ability to catalyze DELTA1-dehydrogenation of steroids with the aliphatic side chain on the C17 position. AcmB indeed exhibits a significantly higher affinity to cholest-4-en-3-one than to 4-androstene-3,17-dione
-
-
-
additional information
?
-
-
enzyme substrate specificity, structure-function analysis. KSTDs catalyze regio- and stereoselective dehydrogenation between C1 and C2 atoms of steroid ring A. AcmB shows ability to catalyze DELTA1-dehydrogenation of steroids with the aliphatic side chain on the C17 position. AcmB indeed exhibits a significantly higher affinity to cholest-4-en-3-one than to 4-androstene-3,17-dione
-
-
-
additional information
?
-
the recombinant enzyme is active with various 3-ketosteroids, including exceptionally the bulky side chain-containing steroids, 4-cholesten-3-one and 25-hydroxycholest-4-en-3-one
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Itagaki, E.; Wakabayashi, T.; Hatta, T.
Purification and characterization of 3-ketosteroid-delta 1-dehydrogenase from Nocardia corallina
Biochim. Biophys. Acta
1038
60-67
1990
Gordonia rubripertincta
brenda
Atrat, P.; Deppmeyer, V.; Hörhold, C.
Efficient purification of a microbial steroid-1-dehydrogenase by electrophoretic desorption from the affinity matrix on a preparative scale
J. Chromatogr.
189
279-283
1980
Rhodococcus opacus
-
brenda
Groh, H.; Komel, R.; Deppmeyer, V.; Atrat, P.; Hörhold, C.
Steroid-transforming enzymes from microorganisms. XI. Reversibility of the dehydrogenation reaction of the steroid-1-dehydrogenase from Nocardia opaca
Z. Allg. Mikrobiol.
19
727-730
1979
Rhodococcus opacus
brenda
Itagaki, E.; Hatta, T.; Wakabayashi, T.; Suzuki, K.
Spectral properties of 3-ketosteroid-delta 1-dehydrogenase from Nocardia corallina
Biochim. Biophys. Acta
1040
281-286
1990
Gordonia rubripertincta
brenda
Kloosterman IV, J.; Lilly, M.D.
Effect of supersaturated aqueous hydrocortison concentrations on the DELTA1-dehydrogenase activity of free and immobilized Arthrobacter simplex
Enzyme Microb. Technol.
6
113-116
1984
Pimelobacter simplex
-
brenda
Penasse, L.; Nomine, G.
The active center of the 3-oxosteroid delta-1-dehydrogenase from Arthrobacter simplex
Eur. J. Biochem.
47
555-559
1974
Pimelobacter simplex
brenda
Aries, V.C.; Goddard, P.; Hill, M.J.
Degradation of steroids by intestinal bacteria. III. 3-Oxo-5beta-steroid DELTA1-dehydrogenase and 3-oxo-5beta-steroid DELTA4-dehydrogenase
Biochim. Biophys. Acta
248
482-488
1971
Clostridium paraputrificum
-
brenda
Rodig, O.R.; Roller, P.P.; Nicholas, A.W.
The stereochemistry of hydrogen addition by a delta1-steroid reductase in bakers yeast
Biochem. Biophys. Res. Commun.
56
467-470
1974
Saccharomyces cerevisiae
brenda
Levy, H.R.; Talalay, P.
Bacterial oxidation of steroids. II. Studies on the enzymatic mechanism of ring A dehydrogenation
J. Biol. Chem.
234
2014-2021
1959
Comamonas testosteroni
brenda
Atrat, P.; Groh, H.
Steroid transformation with immobilized microorganisms. VI. The reverse reaction of steroid-1-dehydrogenases from different micoorganisms in immobilized state
Z. Allg. Mikrobiol.
21
3-6
1981
Mycolicibacterium phlei, Nocardia erythropolis, Rhodococcus opacus
brenda
Udvardy, E.N.; Hantos, G.
Kinetics of the formation of steroid-specific enzymes
FEMS Symp.
13
21-33
1982
Pimelobacter simplex
-
brenda
Hörhold, C.; Atrat, P.; Deppmeyer, V.; Gabert, A.; Flemming, C.; Schubert, K.
Steroid-transforming enzymes from microorganisms. II. Purification of a 3-oxosteroid: (2,6-dichlorophenolindophenol) delta 1-oxidoreductase from Nocardia opaca by means of affinity chromatography
Z. Allg. Mikrobiol.
16
559-561
1976
Rhodococcus opacus
brenda
Lestrovaja, N.N.; Dänhardt, S.; Hörhold, C.
Steroid transforming enzymes from microorganisms. V. Purification of a 4-en-3-oxosteroid: (acceptor)-1-en-oxidoreductase from Nocardia opaca and characterization of the prosthetic group
Z. Allg. Mikrobiol.
18
189-196
1978
Rhodococcus opacus
brenda
Hörhold, C.; Huller, E.; Rose, G.
Steroid-transforming enzymes from microorganisms. XII. Induction characteristics of the 4-en-3-oxosteroid: (acceptor)-1-en-oxidoreductase in Nocardia opaca
Z. Allg. Mikrobiol.
19
731-739
1979
Rhodococcus opacus
brenda
Hörhold, C.; Huller, E.; Rose, G.
Steroid transforming enzymes in microorganisms. XIII. Relationship between steroid structure and induction of 4-ene-3-oxosteroid: (acceptor)-1-ene-oxidoreductase in Nocardia opaca
Z. Allg. Mikrobiol.
20
23-32
1980
Rhodococcus opacus
brenda
Abul-Hajj, Y.J.
Isolation of vitamin K2(35) from Nocardia restrictus and Corynebacterium simplex. A natural electron acceptor in microbial steroid ring A dehydrogenations
J. Biol. Chem.
253
2356-2360
1978
Pimelobacter simplex, Rhodococcus equi, Ilyonectria destructans, Plectosphaerella cucumerina
brenda
Van der Geize, R.; Hessels, G.I.; van Gerwen, R.; van der Meijden, P.; Dijkhuizen, L.
Unmarked gene deletion mutagenesis of kstD, encoding 3-ketosteroid DELTA1-dehydrogenase, in Rhodococcus erythropolis SQ1 using sacB as counter-selectable marker
FEMS Microbiol. Lett.
205
197-202
2001
Rhodococcus erythropolis
brenda
Choi, K.P.; Molnar, I.; Yamashita, M.; Murooka, Y.
Purification and characterization of the 3-ketosteroid-DELTA1-dehydrogenase of Arthrobacter simplex produced in Streptomyces lividans
J. Biochem.
117
1043-1049
1995
Pimelobacter simplex
brenda
Choi, K.P.; Molnar, I.; Murooka, Y.
Secretory overproduction of Arthrobacter simplex 3-ketosteroid DELTA1-dehydrogenase by Streptomyces lividans with a multi-copy shuttle vector
Appl. Microbiol. Biotechnol.
43
1044-1049
1995
Pimelobacter simplex
brenda
Fujii, C.; Morii, S.; Kadode, M.; Sawamoto, S.; Iwami, M.; Itagaki, E.
Essential tyrosine residues in 3-ketosteroid-DELTA1-dehydrogenase from Rhodococcus rhodochrous
J. Biochem.
126
662-667
1999
Rhodococcus rhodochrous
brenda
Molnar, I.; Choi, K.P.; Yamashita, M.; Murooka, Y.
Molecular cloning, expression in Streptomyces lividans, and analysis of a gene cluster from Arthrobacter simplex encoding 3-ketosteroid-DELTA1-dehydrogenase, 3-ketosteroid-DELTA5-isomerase and a hypothetical regulatory protein
Mol. Microbiol.
15
895-905
1995
Pimelobacter simplex
brenda
Morii, S.; Fujii, C.; Miyoshi, T.; Iwami, M.; Itagaki, E.
3-Ketosteroid-DELTA1-dehydrogenase of Rhodococcus rhodochrous: sequencing of the genomic DNA and hyperexpression, purification, and characterization of the recombinant enzyme
J. Biochem.
124
1026-1032
1998
Rhodococcus rhodochrous
brenda
Horinouchi, M.; Hayashi, T.; Yamamoto, T.; Kudo, T.
A new bacterial steroid degradation gene cluster in Comamonas testosteroni TA441 which consists of aromatic-compound degradation genes for seco-steroids and 3-ketosteroid dehydrogenase genes
Appl. Environ. Microbiol.
69
4421-4430
2003
Comamonas testosteroni (Q06401), Comamonas testosteroni TA441 (Q06401)
brenda
van der Geize, R.; Hessels, G.I.; Dijkhuizen, L.
Molecular and functional characterization of the kstD2 gene of Rhodococcus erythropolis SQ1 encoding a second 3-ketosteroid DELTA(1)-dehydrogenase isoenzyme
Microbiology
148
3285-3292
2002
Rhodococcus erythropolis (Q8RLT5), Rhodococcus erythropolis SQ1 (Q8RLT5), Rhodococcus erythropolis SQ1
brenda
Adham, N.Z.; El-Hady, A.A.; Naim, N.
Biochemical studies on the microbial DELTA1-dehydrogenation of cortisol by Pseudomonas fluorescens
Proc. Biochem.
38
897-902
2003
Pseudomonas fluorescens
-
brenda
Brzostek, A.; Sliwinski, T.; Rumijowska-Galewicz, A.; Korycka-Machala, M.; Dziadek, J.
Identification and targeted disruption of the gene encoding the main 3-ketosteroid dehydrogenase in Mycobacterium smegmatis
Microbiology
151
2393-2402
2005
Mycobacterium tuberculosis, Mycolicibacterium smegmatis, Mycolicibacterium smegmatis mc(2)155 / ATCC 700084, Mycobacterium tuberculosis H37Ra / ATCC 25177
brenda
Knol, J.; Bodewits, K.; Hessels, G.I.; Dijkhuizen, L.; van der Geize, R.
3-Keto-5alpha-steroid DELTA(1)-dehydrogenase from Rhodococcus erythropolis SQ1 and its orthologue in Mycobacterium tuberculosis H37Rv are highly specific enzymes that function in cholesterol catabolism
Biochem. J.
410
339-346
2008
Mycobacterium tuberculosis, Rhodococcus erythropolis (A9QAE5), Rhodococcus erythropolis (Q8RLT5), Rhodococcus erythropolis (Q9RA02), Rhodococcus erythropolis, Rhodococcus erythropolis SQ1 (A9QAE5), Rhodococcus erythropolis SQ1 (Q8RLT5), Rhodococcus erythropolis SQ1 (Q9RA02), Rhodococcus erythropolis SQ1, Mycobacterium tuberculosis H37Rv
brenda
Li, Y.; Lu, F.; Sun, T.; Du, L.
Expression of ksdD gene encoding 3-ketosteroid-DELTA1-dehydrogenase from Arthrobacter simplex in Bacillus subtilis
Lett. Appl. Microbiol.
44
563-568
2007
Pimelobacter simplex
brenda
Rohman, A.; van Oosterwijk, N.; Dijkstra, B.W.
Purification, crystallization and preliminary X-ray crystallographic analysis of 3-ketosteroid DELTA1-dehydrogenase from Rhodococcus erythropolis SQ1
Acta Crystallogr. Sect. F
68
551-556
2012
Rhodococcus erythropolis (Q9RA02), Rhodococcus erythropolis SQ1 (Q9RA02)
brenda
Wei, W.; Wang, F.Q.; Fan, S.Y.; Wei, D.Z.
Inactivation and augmentation of the primary 3-ketosteroid-DELTA1-dehydrogenase in Mycobacterium neoaurum NwIB-01: biotransformation of soybean phytosterols to 4-androstene-3,17-dione or 1,4-androstadiene-3,17-dione
Appl. Environ. Microbiol.
76
4578-4582
2010
Mycolicibacterium neoaurum (C6KID9), Mycolicibacterium neoaurum NwIB-01 (C6KID9)
brenda
Chen, M.M.; Wang, F.Q.; Lin, L.C.; Yao, K.; Wei, D.Z.
Characterization and application of fusidane antibiotic biosynethsis enzyme 3-ketosteroid-DELTA1-dehydrogenase in steroid transformation
Appl. Microbiol. Biotechnol.
96
133-142
2012
Aspergillus fumigatus, Aspergillus fumigatus CICC 40167
brenda
Brzezinska, M.; Szulc, I.; Brzostek, A.; Klink, M.; Kielbik, M.; Sulowska, Z.; Pawelczyk, J.; Dziadek, J.
The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis
BMC Microbiol.
13
43
2013
Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv
brenda
Zhang, W.; Shao, M.; Rao, Z.; Xu, M.; Zhang, X.; Yang, T.; Li, H.; Xu, Z.
Bioconversion of 4-androstene-3,17-dione to androst-1,4-diene-3,17-dione by recombinant Bacillus subtilis expressing ksdd gene encoding 3-ketosteroid-DELTA1-dehydrogenase from Mycobacterium neoaurum JC-12
J. Steroid Biochem. Mol. Biol.
135
36-42
2013
Mycolicibacterium neoaurum, Mycolicibacterium neoaurum JC-12
brenda
Rohman, A.; van Oosterwijk, N.; Thunnissen, A.M.; Dijkstra, B.W.
Crystal structure and site-directed mutagenesis of 3-ketosteroid Delta1-dehydrogenase from Rhodococcus erythropolis SQ1 explain its catalytic mechanism
J. Biol. Chem.
288
35559-35568
2013
Rhodococcus erythropolis (Q9RA02), Rhodococcus erythropolis SQ1 (Q9RA02)
brenda
Shao, M.; Zhang, X.; Rao, Z.; Xu, M.; Yang, T.; Li, H.; Xu, Z.; Yang, S.
A mutant form of 3-ketosteroid-Delta(1)-dehydrogenase gives altered androst-1,4-diene-3, 17-dione/androst-4-ene-3,17-dione molar ratios in steroid biotransformations by Mycobacterium neoaurum ST-095
J. Ind. Microbiol. Biotechnol.
43
691-701
2016
Mycolicibacterium neoaurum, Mycolicibacterium neoaurum JC-12, Mycolicibacterium neoaurum ST-095
brenda
Yao, K.; Xu, L.Q.; Wang, F.Q.; Wei, D.Z.
Characterization and engineering of 3-ketosteroid-Delta1-dehydrogenase and 3-ketosteroid-9alpha-hydroxylase in Mycobacterium neoaurum ATCC 25795 to produce 9alpha-hydroxy-4-androstene-3,17-dione through the catabolism of sterols
Metab. Eng.
24
181-191
2014
Mycolicibacterium neoaurum (C8CJG6), Mycolicibacterium neoaurum (W0NR13), Mycolicibacterium neoaurum (W0NUN5), Mycolicibacterium neoaurum ATCC 25795 (C8CJG6), Mycolicibacterium neoaurum ATCC 25795 (W0NR13), Mycolicibacterium neoaurum ATCC 25795 (W0NUN5)
brenda
Guevara, G.; Fernandez de Las Heras, L.; Perera, J.; Navarro Llorens, J.M.
Functional differentiation of 3-ketosteroid Delta(1)-dehydrogenase isozymes in Rhodococcus ruber strain Chol-4
Microb. Cell Fact.
16
42
2017
Rhodococcus ruber (C6GCU2), Rhodococcus ruber (I0B6I6), Rhodococcus ruber (I0B6J0), Rhodococcus ruber, Rhodococcus ruber Chol-4 (C6GCU2), Rhodococcus ruber Chol-4 (I0B6I6), Rhodococcus ruber Chol-4 (I0B6J0)
brenda
Wang, X.; Feng, J.; Zhang, D.; Wu, Q.; Zhu, D.; Ma, Y.
Characterization of new recombinant 3-ketosteroid-DELTA1-dehydrogenases for the biotransformation of steroids
Appl. Microbiol. Biotechnol.
101
6049-6060
2017
Mycolicibacterium neoaurum, Mycolicibacterium neoaurum (C6KID9), Mycolicibacterium neoaurum (C8CJG6), Mycolicibacterium smegmatis (A0QW99), Mycolicibacterium smegmatis (A0R1T2), Mycolicibacterium smegmatis (A0R1T7), Rhodococcus erythropolis (Q9RA02), Rhodococcus erythropolis, Rhodococcus erythropolis WY 1406 (Q9RA02), Rhodococcus erythropolis CGMCC 5096 (Q9RA02), Mycolicibacterium neoaurum 2967 (C6KID9), Mycolicibacterium neoaurum 2966, Mycolicibacterium neoaurum 2966 (C6KID9), Mycolicibacterium neoaurum 2966 (C8CJG6), Mycolicibacterium smegmatis ATCC 700084 (A0QW99), Mycolicibacterium smegmatis ATCC 700084 (A0R1T2), Mycolicibacterium smegmatis ATCC 700084 (A0R1T7), Mycolicibacterium smegmatis mc2155 (A0QW99), Mycolicibacterium smegmatis mc2155 (A0R1T2), Mycolicibacterium smegmatis mc2155 (A0R1T7)
brenda
Zhang, R.; Xu, X.; Cao, H.; Yuan, C.; Yuminaga, Y.; Zhao, S.; Shi, J.; Zhang, B.
Purification, characterization, and application of a high activity 3-ketosteroid-DELTA1-dehydrogenase from Mycobacterium neoaurum DSM 1381
Appl. Microbiol. Biotechnol.
103
6605-6616
2019
Mycolicibacterium neoaurum (A0A2P1IUZ5), Mycolicibacterium neoaurum, Mycolicibacterium neoaurum DSM 1381 (A0A2P1IUZ5)
brenda
Kreit, J.
Aerobic catabolism of sterols by microorganisms key enzymes that open the 3-ketosteroid nucleus
FEMS Microbiol. Lett.
366
fnz173
2019
Gordonia rubripertincta, Gordonia neofelifaecis, Mycolicibacterium smegmatis (A0R4S9), Sterolibacterium denitrificans (A9XWD7), Rhodococcus ruber (C6GCU2), Rhodococcus ruber (I0B6I6), Rhodococcus ruber (I0B6J0), Mycobacterium tuberculosis (P71864), Rhodococcus erythropolis (Q9RA02), Rhodococcus erythropolis SQ1 (Q9RA02), Mycolicibacterium smegmatis ATCC 700084 (A0R4S9), Mycobacterium tuberculosis H37Rv (P71864), Gordonia neofelifaecis NRRL B-59395, Mycolicibacterium smegmatis mc(2)155 (A0R4S9)
brenda
Luo, J.M.; Cui, H.L.; Jia, H.C.; Li, F.; Cheng, H.J.; Shen, Y.B.; Wang, M.
Identification, biological characteristics, and active site residues of 3-ketosteroid DELTA1-dehydrogenase homologues from Arthrobacter simplex
J. Agric. Food Chem.
68
9496-9512
2020
Pimelobacter simplex, Pimelobacter simplex CGMCC 14539
brenda
Zhang, R.; Liu, X.; Wang, Y.; Han, Y.; Sun, J.; Shi, J.; Zhang, B.
Identification, function, and application of 3-ketosteroid DELTA1-dehydrogenase isozymes in Mycobacterium neoaurum DSM 1381 for the production of steroidic synthons
Microb. Cell Fact.
17
77
2018
Mycolicibacterium neoaurum (A0A2P1IUY8), Mycolicibacterium neoaurum (A0A2P1IUZ1), Mycolicibacterium neoaurum (A0A2P1IUZ5), Mycolicibacterium neoaurum, Mycolicibacterium neoaurum DSM 1381 (A0A2P1IUY8), Mycolicibacterium neoaurum DSM 1381 (A0A2P1IUZ1), Mycolicibacterium neoaurum DSM 1381 (A0A2P1IUZ5)
brenda
Wojcik, P.; Glanowski, M.; Wojtkiewicz, A.M.; Rohman, A.; Szaleniec, M.
Universal capability of 3-ketosteroid ?1-dehydrogenases to catalyze DELTA1-dehydrogenation of C17-substituted steroids
Microb. Cell Fact.
20
119
2021
Sterolibacterium denitrificans (A0A656Z7Q3), Sterolibacterium denitrificans (A9XWD7), Sterolibacterium denitrificans, Rhodococcus erythropolis (Q9RA02), Rhodococcus erythropolis
brenda
D'Arcy, B.M.; Swingle, M.R.; Schambeau, L.; Pannell, L.; Prakash, A.; Honkanen, R.E.
Development of a synthetic 3-ketosteroid DELTA1-dehydrogenase for the generation of a novel catabolic pathway enabling cholesterol degradation in human cells
Sci. Rep.
9
5969
2019
no activity in Homo sapiens, Rhodococcus erythropolis (Q9RA02), Sterolibacterium denitrificans (A9XWD7)
brenda
Qin, N.; Shen, Y.; Yang, X.; Su, L.; Tang, R.; Li, W.; Wang, M.
Site-directed mutagenesis under the direction of in silico protein docking modeling reveals the active site residues of 3-ketosteroid-DELTA1-dehydrogenase from Mycobacterium neoaurum
World J. Microbiol. Biotechnol.
33
146
2017
Mycolicibacterium neoaurum (C6KID9), Mycolicibacterium neoaurum MNR (C6KID9), Mycolicibacterium neoaurum TCCC 11028 (C6KID9)
brenda